Niraparib is a medication that belongs to a class of drugs known as poly (ADP-ribose) polymerase (PARP) inhibitors. It is commonly used in the treatment of certain types of cancer, particularly ovarian cancer. Niraparib works by blocking the PARP enzyme, which plays a key role in repairing damaged DNA in cancer cells. By inhibiting this enzyme, Niraparib helps to prevent cancer cells from repairing themselves, ultimately leading to their death.

Patients who are prescribed Niraparib should be aware of the potential side effects associated with this medication. Common side effects may include nausea, fatigue, anemia, and changes in blood cell counts. It is important for patients to communicate any side effects they may experience to their healthcare provider, as they may require adjustments to their treatment plan.

As with any medication, it is important for patients to follow their healthcare provider’s instructions carefully when taking Niraparib. This may include taking the medication at the same time each day, with or without food, and avoiding certain medications or supplements that may interact with Niraparib.

It is also important for patients to inform their healthcare provider of any other medical conditions they may have, as well as any other medications or supplements they may be taking. This will help to ensure that Niraparib is safe and effective for them.

Overall, Niraparib is a valuable medication in the treatment of certain types of cancer, and can help to improve outcomes for patients. By working closely with their healthcare provider and following their treatment plan, patients can maximize the benefits of Niraparib while minimizing any potential risks.